186 related articles for article (PubMed ID: 28332630)
1. PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.
Salsman J; Stathakis A; Parker E; Chung D; Anthes LE; Koskowich KL; Lahsaee S; Gaston D; Kukurba KR; Smith KS; Chute IC; Léger D; Frost LD; Montgomery SB; Lewis SM; Eskiw C; Dellaire G
Sci Rep; 2017 Mar; 7():45038. PubMed ID: 28332630
[TBL] [Abstract][Full Text] [Related]
2. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
[TBL] [Abstract][Full Text] [Related]
3. Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.
Wang Y; Han E; Xing Q; Yan J; Arrington A; Wang C; Tully D; Kowolik CM; Lu DM; Frankel PH; Zhai J; Wen W; Horne D; Yip MLR; Yim JH
Cancer Lett; 2015 Mar; 358(2):170-179. PubMed ID: 25543165
[TBL] [Abstract][Full Text] [Related]
4. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
5. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
6. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
7. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
Fuchsová B; Novák P; Kafková J; Hozák P
J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
9. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
10. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.
Salsman J; Rapkin LM; Margam NN; Duncan R; Bazett-Jones DP; Dellaire G
Cell Death Dis; 2017 Mar; 8(3):e2724. PubMed ID: 28358373
[TBL] [Abstract][Full Text] [Related]
11. Translational control of PML contributes to TNFα-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs.
Hsu KS; Guan BJ; Cheng X; Guan D; Lam M; Hatzoglou M; Kao HY
Cell Death Differ; 2016 Mar; 23(3):469-83. PubMed ID: 26383972
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
13. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
[TBL] [Abstract][Full Text] [Related]
14. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
[TBL] [Abstract][Full Text] [Related]
15. PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair.
Vancurova M; Hanzlikova H; Knoblochova L; Kosla J; Majera D; Mistrik M; Burdova K; Hodny Z; Bartek J
DNA Repair (Amst); 2019 Jun; 78():114-127. PubMed ID: 31009828
[TBL] [Abstract][Full Text] [Related]
16. Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.
Bienkowska-Haba M; Luszczek W; Keiffer TR; Guion LGM; DiGiuseppe S; Scott RS; Sapp M
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27860076
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
18. Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.
Fang W; Mori T; Cobrinik D
Oncogene; 2002 Aug; 21(36):5557-65. PubMed ID: 12165854
[TBL] [Abstract][Full Text] [Related]
19. PML modulates epigenetic composition of chromatin to regulate expression of pro-metastatic genes in triple-negative breast cancer.
Fracassi C; Ugge' M; Abdelhalim M; Zapparoli E; Simoni M; Magliulo D; Mazza D; Lazarevic D; Morelli MJ; Collas P; Bernardi R
Nucleic Acids Res; 2023 Nov; 51(20):11024-11039. PubMed ID: 37823593
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.
Chung YL; Tsai TY
Mol Cancer Res; 2009 Oct; 7(10):1672-85. PubMed ID: 19808906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
